Allergan To Buy Kythera, Beat Kybella Peak Forecasts, Saunders Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Botox maker will buy Kythera for $2.1 billion, gaining the newly approved Kybella, a non-surgical treatment for excessive fat under the chin.